Личный профиль
Personal profile
Research interests
Publications
Образование/академическая квалификация
Drug Discovery , PhD
Fingerprint
- 1 Аналогичные профили
Коллаборации и основные области исследования за последние пять лет
-
Antimicrobial Resistance Study in Kazakhstan: Community Antibiotic Consumption and Resistance Rates
Semenova, Y. (PI) & Aljofan, M. (Co-PI)
2/4/25 → 12/31/27
Проект
-
Investigating endoplasmic reticulum oxidoreductase 1 alpha and protein disulfide isomerase interface as a potential target for anticancer therapy
Aljofan, M. (PI), Gulyayev, A. (Co-PI), Nurkenov , O. A. (Co-PI), Koes, D. (Co-PI), Saktashev, B. (Other Faculty/Researcher) & Poon , I. (Other Faculty/Researcher)
1/1/25 → 12/31/27
Проект
-
An AI-based Approach for Analyzing Electronic Medical Records: Prediction of Healthcare Outcomes and Drug Demand
Gaipov, A. (PI), Aljofan, M. (Other Faculty/Researcher), Zollanvari, A. (Co-PI), Şen , F. (Other Faculty/Researcher), Aimyshev, T. (Other Faculty/Researcher), Yerdessov, S. (Other Faculty/Researcher) & Zhakhina, G. (Other Faculty/Researcher)
1/1/24 → 12/31/26
Проект
-
MEPD: Mare’s milk-derived exosomes for polyphenols delivery
Aljofan, M. (PI), Gulyayev, A. (Co-PI) & Turmukhambetova, A. (Co-PI)
1/1/21 → 12/10/24
Проект
-
Author Correction: Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study (Nature Medicine, (2026), 32, 1, (197-223), 10.1038/s41591-025-04077-9)
GBD 2023 Global Chronic Respiratory Disease and Covid Collaborators, мар. 2026, В: Nature Medicine. 32, 3, стр. 1160 1 стр.Результат исследований › рецензирование
Открытый доступ -
Forecasting the future burden of major diseases in Kazakhstan using global burden of disease and time series models (ARIMA, Prophet, LSTM), 2019-2032
Maulenkul, T., Aimyshev, T., Oshibayeva, A., Yazici, A., Aljofan, M., Japparkulova, A. & Gaipov, A., февр. 2026, В: Electronic Journal of General Medicine. 23, 1, em710.Результат исследований › рецензирование
Открытый доступ -
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
GBD 2023 Global Chronic Respiratory Disease and Covid Collaborators, янв. 2026, В: Nature Medicine. 32, 1, стр. 197-223 27 стр.Результат исследований › рецензирование
Открытый доступ3 !!Link opens in a new tab Цитирования (Scopus) -
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
Oh, J., Kim, S., Yim, Y., Kim, M. S., Il Shin, J., Jabbar, A. A. J., Aalruz, H., Abbasian, M., Abd Al Magied, A. H. A., ElHafeez, S. A., Abdelkader, A., Abdelmagied, M. H., Abdi, P., Abdollahifar, M.-A., Abdulah, D. M., Abdullahi, A., Abebaw, N., Zuñiga, R. A. A., Aboagye, R. G. & Abolhassani, H. и 279 др., , янв. 2026, В: Nature Medicine.Результат исследований › рецензирование
-
Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha–Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer
Aljofan, M., янв. 23 2026, В: BioMedicine (Netherlands).Результат исследований › рецензирование
-
-
-
-
Establishment and validation of mare’s milkderived exosomes extraction method
Aljofan, M. (Speaker)
июн. 25 2022Деятельность
-